Korro Bio Statistics

Total Valuation

Korro Bio has a market cap or net worth of $478.91 million. The enterprise value is $312.98 million.

Market Cap	478.91M
Enterprise Value	312.98M

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

Korro Bio has 9.37 million shares outstanding. The number of shares has increased by 31.62% in one year.

Current Share Class	9.37M
Shares Outstanding	9.37M
Shares Change (YoY)	+31.62%
Shares Change (QoQ)	+3.52%
Owned by Insiders (%)	6.43%
Owned by Institutions (%)	45.00%
Float	4.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.44
P/TBV Ratio	2.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.23, with a Debt / Equity ratio of 0.23.

Current Ratio	11.23
Quick Ratio	10.80
Debt / Equity	0.23
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -74.51% and return on invested capital (ROIC) is -38.78%.

Return on Equity (ROE)	-74.51%
Return on Assets (ROA)	-35.27%
Return on Capital (ROIC)	-38.78%
Revenue Per Employee	n/a
Profits Per Employee	-$860,863
Employee Count	102
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Korro Bio has paid $38,000 in taxes.

Income Tax	38,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +20.54% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+20.54%
50-Day Moving Average	50.48
200-Day Moving Average	51.58
Relative Strength Index (RSI)	38.33
Average Volume (20 Days)	124,441

Short Selling Information

The latest short interest is 261,960, so 2.80% of the outstanding shares have been sold short.

Short Interest	261,960
Short Previous Month	274,235
Short % of Shares Out	2.80%
Short % of Float	5.90%
Short Ratio (days to cover)	1.57

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-95.76M
Pretax Income	-81.17M
Net Income	-87.81M
EBITDA	-92.47M
EBIT	-95.76M
Earnings Per Share (EPS)	-$11.11

Full Income Statement

Balance Sheet

The company has $137.00 million in cash and $41.79 million in debt, giving a net cash position of $127.33 million or $13.59 per share.

Cash & Cash Equivalents	137.00M
Total Debt	41.79M
Net Cash	127.33M
Net Cash Per Share	$13.59
Equity (Book Value)	179.63M
Book Value Per Share	19.28
Working Capital	139.17M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$73.69 million and capital expenditures -$18.11 million, giving a free cash flow of -$91.79 million.

Operating Cash Flow	-73.69M
Capital Expenditures	-18.11M
Free Cash Flow	-91.79M
FCF Per Share	-$9.80

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Korro Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-31.62%
Shareholder Yield	-31.62%
Earnings Yield	-19.94%
FCF Yield	-20.85%

Analyst Forecast

The average price target for Korro Bio is $133.83, which is 161.80% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$133.83
Price Target Difference	161.80%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-27.17%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2